These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2410098)
1. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Verhoef V; Fridland A Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and selectivity of arabinonucleoside in human lymphoid cells. Fridland A; Verhoef V Proc Soc Exp Biol Med; 1985 Sep; 179(4):456-62. PubMed ID: 2991939 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. Shewach DS; Daddona PE; Ashcraft E; Mitchell BS Cancer Res; 1985 Mar; 45(3):1008-14. PubMed ID: 3971358 [TBL] [Abstract][Full Text] [Related]
4. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells. Shewach DS; Mitchell BS Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707 [TBL] [Abstract][Full Text] [Related]
5. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920 [TBL] [Abstract][Full Text] [Related]
6. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Gandhi V; Plunkett W Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008 [TBL] [Abstract][Full Text] [Related]
7. Interaction of arabinosyl nucleotides in K562 human leukemia cells. Gandhi V; Plunkett W Biochem Pharmacol; 1989 Oct; 38(20):3551-8. PubMed ID: 2479383 [TBL] [Abstract][Full Text] [Related]
8. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate. Liliemark JO; Plunkett W Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676 [TBL] [Abstract][Full Text] [Related]
10. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step. Rodriguez CO; Gandhi V Cancer Res; 1999 Oct; 59(19):4937-43. PubMed ID: 10519407 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells. Rodriguez CO; Legha JK; Estey E; Keating MJ; Gandhi V Clin Cancer Res; 1997 Nov; 3(11):2107-13. PubMed ID: 9815603 [TBL] [Abstract][Full Text] [Related]
12. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity. Tanaka M; Yoshida S Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933 [TBL] [Abstract][Full Text] [Related]
13. 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies. Lambe CU; Averett DR; Paff MT; Reardon JE; Wilson JG; Krenitsky TA Cancer Res; 1995 Aug; 55(15):3352-6. PubMed ID: 7614470 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate. Catapano CV; Chandler KB; Fernandes DJ Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219 [TBL] [Abstract][Full Text] [Related]
15. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070 [TBL] [Abstract][Full Text] [Related]
16. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. Gandhi V; Estey E; Du M; Keating MJ; Plunkett W Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841 [TBL] [Abstract][Full Text] [Related]
17. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I; Saito S; Hori K; Suzuki M; Sato H Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175 [TBL] [Abstract][Full Text] [Related]
18. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule. Seymour JF; Huang P; Plunkett W; Gandhi V Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells. Xie C; Plunkett W Cancer Res; 1995 Jul; 55(13):2847-52. PubMed ID: 7540950 [TBL] [Abstract][Full Text] [Related]
20. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine. Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]